TACE Plus Lenvatinib and Tislelizumab for Intermediate-Stage Hepatocellular Carcinoma Beyond Up-to-11 Criteria: a Multicenter Cohort Study
FRONTIERS IN IMMUNOLOGY（2024）
Key words
hepatocellular carcinoma,intermediate-stage,up-to-eleven criteria,transartrial chemoembolization,combination therapy
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined